Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every ...

It’s unfortunate that for a very long time, there has been a misconception that Black people can’t get skin cancer. This belief stems from the fact that melanin provides some natural protection ...

Sarah Eggenberger thought the red dot on her nose was a sign of aging. When it persisted, she saw a new doctor and learned ...

The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

The study was pretty simple. Researchers analyzed health records from nearly 34,000 American veterans and discovered that those who took 500 milligrams twice a day of nicotinamide for at least 30 days ...

A new large-scale study has found that nicotinamide, a common vitamin B3 supplement, may significantly reduce the risk of ...

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...

Nicotinamide, a form of vitamin B people can get over the counter at pharmacies, can reduce the risk of skin cancer returning ...

Regeneron Pharmaceuticals' Libtayo won approval to treat certain patients with cutaneous squamous cell carcinoma, a type of skin cancer, from the Food and Drug Administration. The pharmaceutical ...